An overview of triple-negative breast cancer

P Kumar, R Aggarwal - Archives of gynecology and obstetrics, 2016 - Springer
Purpose Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors
comprising various breast cancers simply defined by the absence of estrogen receptor …

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer

R Chmelar, G Buchanan, EF Need… - … Journal of cancer, 2007 - Wiley Online Library
The androgen receptor signaling axis plays an essential role in the development, function
and homeostasis of male urogenital structures including the prostate gland although the …

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

AS Doane, M Danso, P Lal, M Donaton, L Zhang… - Oncogene, 2006 - nature.com
Little is known of the underlying biology of estrogen receptor-negative, progesterone
receptor-negative (ER (−)/PR (−)) breast cancer (BC), and few targeted therapies are …

Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer

AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto… - Cancer research, 2009 - AACR
There is emerging evidence that the balance between estrogen receptor-α (ERα) and
androgen receptor (AR) signaling is a critical determinant of growth in the normal and …

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

F De Amicis, J Thirugnansampanthan, Y Cui… - Breast cancer research …, 2010 - Springer
Although the androgen receptor (AR) is a known clinical target in prostate cancer, little is
known about its possible role in breast cancer. We have investigated the role of AR …

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

Y Ogawa, E Hai, K Matsumoto, K Ikeda… - International journal of …, 2008 - Springer
Background Breast cancer is a hormone-dependent tumor. Most breast cancer cells have an
androgen receptor (AR), but the clinical value of AR expression is unclear. Methods AR …

Progesterone: therapeutic opportunities for neuroprotection and myelin repair

M Schumacher, R Guennoun, DG Stein… - Pharmacology & …, 2007 - Elsevier
Progesterone and its metabolites promote the viability of neurons in the brain and spinal
cord. Their neuroprotective effects have been documented in different lesion models …

Evaluation of prenatal exposure to bisphenol analogues on development and long-term health of the mammary gland in female mice

DK Tucker, S Hayes Bouknight, SS Brar… - Environmental …, 2018 - ehp.niehs.nih.gov
Background: Continued efforts to phase out bisphenol A (BPA) from consumer products
have been met with the challenges of finding safer alternatives. Objectives: This study aimed …

AR collaborates with ERα in aromatase inhibitor-resistant breast cancer

Y Rechoum, D Rovito, D Iacopetta, I Barone… - Breast cancer research …, 2014 - Springer
Androgen receptor (AR) is an attractive target in breast cancer because of its frequent
expression in all the molecular subtypes, especially in estrogen receptor (ER)-positive …

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of …

MD Williams, D Roberts… - The American journal …, 2007 - journals.lww.com
Salivary duct carcinoma (SDC), a rare malignancy, manifests remarkable morphologic and
biologic resemblance to high-grade mammary ductal carcinoma. We contend that, similar to …